Worse Neurological State During Acute Ischemic Stroke is Associated with a Decrease in Serum Albumin Levels

[1]  J. Golmard,et al.  S100B blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study , 2014, Clinical chemistry and laboratory medicine.

[2]  Jason K. W. Lee,et al.  S100B as a Marker for Brain Damage and Blood–Brain Barrier Disruption Following Exercise , 2014, Sports Medicine.

[3]  A. Munshi,et al.  Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. , 2013, Nutrition.

[4]  N. Zhang,et al.  Albumin induces neuroprotection against ischemic stroke by altering Toll-like receptor 4 and regulatory T cells in mice. , 2013, CNS & neurological disorders drug targets.

[5]  A. Kisialiou,et al.  Blood biomarkers role in acute ischemic stroke patients: higher is worse or better? , 2012, Immunity & Ageing.

[6]  A. Obenaus,et al.  Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion: a laser speckle contrast flow study , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  A. Słowik,et al.  Serum albumin as a determinant of cortisol release in patients with acute ischemic stroke. , 2012, Atherosclerosis.

[8]  R. Aquilani,et al.  Supplementation of essential amino acids may reduce the occurrence of infections in rehabilitation patients with brain injury. , 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[9]  J. Valero,et al.  Albumin attenuates DNA damage in primary-cultured neurons , 2009, Neuroscience Letters.

[10]  Y. Funakoshi,et al.  Serum S-100B protein levels in left- and right-hemisphere strokes , 2008, Journal of Clinical Neuroscience.

[11]  A. Słowik,et al.  Serum albumin level and nosocomial pneumonia in stroke patients , 2006, European journal of neurology.

[12]  H. Milionis,et al.  Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals. , 2005, International journal of cardiology.

[13]  A. Słowik,et al.  Serum Albumin Level as a Predictor of Ischemic Stroke Outcome , 2004, Stroke.

[14]  J Perl,et al.  Serum S-100β as a possible marker of blood–brain barrier disruption , 2002, Brain Research.

[15]  Weizhao Zhao,et al.  Albumin Therapy of Transient Focal Cerebral Ischemia: In Vivo Analysis of Dynamic Microvascular Responses , 2002, Stroke.

[16]  R. Sprengelmeyer,et al.  S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. , 1997, Stroke.

[17]  L. Parnetti,et al.  Hemorheologic Factors in the Postacute Phase of Ischemic Stroke , 1988, Angiology.

[18]  Feng-ling,et al.  Enhanced Neuroprotection by Local Intra-Arterial Infusion of Human Albumin Solution and Local Hypothermia , 2013 .

[19]  T. Sobrino,et al.  Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke , 2009, Clinical chemistry and laboratory medicine.

[20]  H. Liu,et al.  Neovasculature and blood-brain barrier in ischemic brain infarct , 2004, Acta Neuropathologica.